
(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
The Job of a Land Legal counselor in Property Exchanges - 2
Popular Home Rug Series For You - 3
'Something Very Bad Is Going to Happen' is the Duffer Brothers' first project since 'Stranger Things.' It's also 'wildly insane.' - 4
7 Peculiar Ways Of starting Your Imagination: Motivation Has Never Been This Good times - 5
Explainer-Why are hepatitis B vaccines given to newborns?
Affordable Care Act enrollment is slightly ahead of last year, despite expiring subsidies
UK to hold fresh pork, other affected Spanish products at border amid African swine fever outbreak
NASA Perseverance rover sees megaripples on Mars | Space photo of the day for Jan. 7, 2026.
U.K. blocks Kanye West from entering Britain to headline now canceled festival: What led to the ban
Paul Feig loves a plot twist. Why not reboot 'Die Hard' starring a woman?
How C-reactive protein outpaced ‘bad’ cholesterol as leading heart disease risk marker
Hubble Space Telescope spies dusty debris from two cosmic collisions
Change Your Physical make-up: Compelling Activities for Muscle Building
The Meaning of Breaking the Pen's Nib in Death penalties













